9/10 spin offs are successul in a good marker condition, and provide long term upscale in SP price of the spun off company, according to American stock exchange history.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
Won't be dilution...just a portion of shares for every share you have in Auz... 1 share in the new company for every 100 in Auz..or something similar...
